Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Bioallied Sci ; 6(4): 241-5, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25400406

RESUMO

AIM OF THE STUDY: The synthesis, characterization and application of biologically synthesized nanomaterials are an important aspect in nanotechnology. MATERIALS AND METHODS: The present study deals with the synthesis of silver nanoparticles (Ag-NPs) using the coconut water (C. nucifera) as the reducing agent. The formation of Ag-NPs was characterized by UV-Visible Spectroscopy, Scanning Electron Microscopy (SEM), EDX, X-ray Diffraction (XRD) and FTIR spectroscopy. RESULTS: The synthesized Ag-NPs were predominately polydispersed. Crystalline nature of the nanoparticle in the face centered cubic (fcc) structure are confirmed by the peaks in the XRD pattern corresponding to (111), (200), (220) and (311) planes. Fourier Transform Infra-Red (FT-IR) spectroscopy analysis showed that the synthesized nanoparicles was capped with bimolecular compounds which are responsible for the reduction of silver ions. CONCLUSION: The approach of green synthesis appears to be cost efficient, ecofriendly and easy alternative to conventional methods of silver nanoparticle synthesis.

2.
Arch Oral Biol ; 58(1): 94-101, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22776109

RESUMO

OBJECTIVE: Malignant tumour arises due to abnormal cell proliferation, chronic inflammation, defect in apoptotic pathway and unwanted angiogenesis. The present study has investigated the modulating effect of apigenin on expression pattern of apoptotic (p53, Bcl-2, Bax, Caspase-3 and 9) cell proliferative (PCNA, Cyclin D1, c-fos), angiogenic (VEGF) and inflammatory (NFκB, COX-2) markers during 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch carcinogenesis. MATERIALS AND METHODS: Oral squamous cell carcinoma was developed in the buccal pouches of golden Syrian hamsters by painting with 0.5% DMBA three times a week for 14 weeks. Deregulation in the expression of the cell proliferation, apoptosis, inflammation and angiogenesis markers was noticed in hamsters treated with DMBA alone. RESULTS: Oral administration of apigenin at a dose of 2.5mg/kgbw prevented the deregulation of the above mentioned molecular markers in hamsters treated with DMBA. CONCLUSION: Our results thus suggest that apigenin exhibited anti-cell proliferative, anti-inflammatory, anti-angiogenic and apoptotic potential during DMBA-induced hamster buccal pouch carcinogenesis.


Assuntos
9,10-Dimetil-1,2-benzantraceno/efeitos adversos , Proteínas Angiogênicas/análise , Anticarcinógenos/uso terapêutico , Apigenina/uso terapêutico , Apoptose/efeitos dos fármacos , Carcinógenos/farmacologia , Carcinoma de Células Escamosas/induzido quimicamente , Mediadores da Inflamação/análise , Neoplasias Bucais/induzido quimicamente , Inibidores da Angiogênese/uso terapêutico , Animais , Anti-Inflamatórios/uso terapêutico , Carcinoma de Células Escamosas/patologia , Caspase 3/efeitos dos fármacos , Caspase 9/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Cricetinae , Ciclina D1/efeitos dos fármacos , Ciclo-Oxigenase 2/efeitos dos fármacos , Masculino , Mesocricetus , Neoplasias Bucais/patologia , NF-kappa B/efeitos dos fármacos , Antígeno Nuclear de Célula em Proliferação/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-fos/efeitos dos fármacos , Proteína Supressora de Tumor p53/efeitos dos fármacos , Fator A de Crescimento do Endotélio Vascular/efeitos dos fármacos , Proteína X Associada a bcl-2/efeitos dos fármacos
3.
Artigo em Inglês | MEDLINE | ID: mdl-24082331

RESUMO

The present study has investigated the modulating effect of carnosic acid on the expression pattern of cell proliferative (proliferating cell nuclear antigen (PCNA) cyclin D1 and a transcription factor c-fos), apoptotic (p53, Bcl-2, Bax caspase -3 and 9), inflammatory (Nuclear factor kappa B (NFκB) and cyclooxygenase-2 (COX- 2) and angiogenic (vascular endothelial growth factor (VEGF) markers during 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch carcinogenesis. Oral tumors were developed in the hamsters buccal pouches by painting with 0.5% DMBA in liquid paraffin three times a week for 14 weeks. Hundred per cent tumour formation (well-differentiated squamous cell carcinoma) accompanied by deregulation in the above mentioned molecular markers was noticed in hamsters treated with DMBA alone (tumour bearing hamsters). Oral administration of carnosic acid at dose of 10mg/kg bw to hamsters treated with DMBA not only completely prevented the tumour formation, but also corrected the abnormalities in the expression pattern of molecular markers. The present study suggests that carnosic acid might have inhibited the tumour formation by exerting anti-cell-proliferative, anti-inflammatory, anti-angiogenic and apoptotic potential during DMBA-induced hamster buccal pouch carcinogenesis.


Assuntos
Abietanos/uso terapêutico , Inibidores da Angiogênese/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Anticarcinógenos/uso terapêutico , Carcinoma de Células Escamosas/prevenção & controle , Neoplasias Bucais/prevenção & controle , Extratos Vegetais/uso terapêutico , Rosmarinus/química , 9,10-Dimetil-1,2-benzantraceno , Abietanos/farmacologia , Inibidores da Angiogênese/farmacologia , Animais , Anti-Inflamatórios/farmacologia , Anticarcinógenos/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Antineoplásicos Fitogênicos/uso terapêutico , Apoptose/efeitos dos fármacos , Biomarcadores/metabolismo , Carcinogênese/efeitos dos fármacos , Carcinoma de Células Escamosas/induzido quimicamente , Carcinoma de Células Escamosas/metabolismo , Proliferação de Células/efeitos dos fármacos , Ciclina D1/metabolismo , Mediadores da Inflamação/metabolismo , Masculino , Mesocricetus , Neoplasias Bucais/induzido quimicamente , Neoplasias Bucais/metabolismo , Fitoterapia , Extratos Vegetais/farmacologia , Antígeno Nuclear de Célula em Proliferação/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo
4.
Eur J Pharmacol ; 670(2-3): 571-7, 2011 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-21970806

RESUMO

Aim was to investigate the chemopreventive potential of apigenin by analyzing the tumor incidence as well as monitoring lipid peroxidation, antioxidants and phase I and phase II detoxification as biomarkers during DMBA induced hamster buccal pouch carcinogenesis. Oral tumors were developed in the buccal pouches of golden Syrian hamsters using topical application of 0.5% DMBA (DMBA) three times a week for 14weeks. Tumor incidence, tumor volume and burden were measured in hamsters treated with 7,12-dimethylbenz(a)anthracene and DMBA+apigenin (2.5mg/kg body weight) treated hamsters. Oral administration of apigenin not only completely prevented the formation of oral tumors, it also brought back the status of lipid peroxidation, antioxidants and phase I and phase II detoxification agents to near normal range during DMBA induced oral carcinogenesis. The present study thus concludes that apigenin might have inhibited oral carcinogenesis by improving the status of antioxidant defense mechanism and modulated the activities of phase I and phase II detoxification cascade toward increased excretion of active metabolite of DMBA, during DMBA induced hamster buccal pouch carcinogenesis.


Assuntos
9,10-Dimetil-1,2-benzantraceno/toxicidade , Apigenina/farmacologia , Neoplasias Bucais/induzido quimicamente , Neoplasias Bucais/prevenção & controle , Animais , Antioxidantes/metabolismo , Apigenina/uso terapêutico , Quimioprevenção , Cricetinae , Modelos Animais de Doenças , Fígado/efeitos dos fármacos , Fígado/metabolismo , Desintoxicação Metabólica Fase I , Desintoxicação Metabólica Fase II , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/metabolismo , Mucosa Bucal/patologia , Neoplasias Bucais/metabolismo , Neoplasias Bucais/patologia , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
5.
Chem Biol Interact ; 188(3): 616-22, 2010 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-20816777

RESUMO

The present study was aimed to investigate the chemopreventive potential of carnosic acid in 7,12-dimethylbenz(a)anthracene (DMBA)-induced hamster buccal pouch carcinogenesis. The chemopreventive potential was assessed by analyzing the tumor incidence, tumor volume and burden as well as by measuring the status of lipid peroxidation, non-enzymatic and enzymatic antioxidants and phase I and phase II detoxification enzymes. Oral squamous cell carcinoma was developed in the buccal pouch of golden Syrian hamsters by painting with 0.5% DMBA in liquid paraffin three times a week for 14 weeks. In the present study, 100% tumor formation was observed in hamsters treated with DMBA alone. Also, the status of lipid peroxidation, antioxidants and phase I and phase II detoxification enzymes were significantly altered during DMBA-induced oral carcinogenesis. Oral administration of carnosic acid at a dose of 10mg/kg body weight/day to DMBA-treated animals completely prevented the tumor formation in the hamsters' buccal pouches. Also, carnosic acid exerted potent anti-lipid peroxidative function and stimulated the detoxification cascade during DMBA-induced hamster buccal pouch carcinogenesis. The results of the present study suggest that the chemopreventive potential of carnosic acid is probably due to its anti-lipid peroxidative potential and modulating effect on carcinogen detoxification enzymes during DMBA-induced oral carcinogenesis.


Assuntos
Abietanos/farmacologia , Anticarcinógenos/farmacologia , Neoplasias Bucais/patologia , Neoplasias Bucais/prevenção & controle , Extratos Vegetais/farmacologia , 9,10-Dimetil-1,2-benzantraceno/toxicidade , Animais , Antioxidantes/metabolismo , Cricetinae , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Desintoxicação Metabólica Fase I , Desintoxicação Metabólica Fase II , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/metabolismo , Neoplasias Bucais/induzido quimicamente , Neoplasias Bucais/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Carga Tumoral/efeitos dos fármacos
6.
Pharmacol Rep ; 62(6): 1170-7, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21273674

RESUMO

Carnosic acid, a primary phenolic compound found in the leaves of rosemary (Rosmarinus officinalis), has diverse pharmacological and biological activities. The aim of the present study was to investigate the anti-clastogenic effect of carnosic acid in DMBA-induced clastogenesis. The frequency of bone marrow micronucleated polychromatic erythrocytes (MnPCEs), chromosomal aberrations (cytogenetic end points), the status of Phase I and II detoxification enzymes, lipid peroxidation by-products and antioxidants (biochemical endpoints) were analyzed to assess the anti-clastogenic effect of carnosic acid in DMBA-induced clastogenesis. Oral pretreatment of carnosic acid for five days to DMBA-treated hamsters significantly protected DMBA-induced clastogenesis as well as biochemical abnormalities. Although the exact mechanism of anti-clastogenic effects of carnosic acid is unclear, the antioxidant potential and effect on modulation of Phase I and II detoxification enzymes could play a possible role.


Assuntos
9,10-Dimetil-1,2-benzantraceno/toxicidade , Abietanos/farmacologia , Anticarcinógenos/farmacologia , Aberrações Cromossômicas/induzido quimicamente , Aberrações Cromossômicas/efeitos dos fármacos , Mutagênicos/toxicidade , Extratos Vegetais/farmacologia , Animais , Ensaio Cometa , Cricetinae , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Mesocricetus , Desintoxicação Metabólica Fase I , Desintoxicação Metabólica Fase II , Testes para Micronúcleos , Rosmarinus
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...